Top Biotech Stock Picks
Posted on Wednesday, July 23rd, 2008 | In Biotech, Market Commentary, Stocks to Watch
Contributed by: CEO Blogger (http://ceoblogger.wordpress.com) -
Christopher Raymond, biotech analyst at Robert W. Baird, picked his top 3 stocks in a CNBC interview; he says Biotech doesnt have growth issues like Big Pharma and mid-caps are prime takeover candidates:
a. BioMarin Pharmaceuticals- small company with strong growth and takeover target
b. Human Genome
c. Genzyme
Track Robert W. Baird Analysts picks at:
http://trackthepros.com/categories.php?category_id=697
Jason Zhang, Sr. Biotech analyst at BMO Capital Markets, picked his top 3 as well; he says several big cap Bios outperformed street expectations and the sector is now a defensive play.
a. Biogen Idec
b. OSI Pharmaceuticals
c. Celgene- expensive, but worth it with strong growth top and bottom line
Track BMO Capital Markets picks at:
Last 5 posts by CEO Blogger
- With its Pension Fund Grab, is it ‘Déjà Vu All Over Again’ For Argentina? - November 18th, 2008
- Exxon Mobil Posts Record $14.8 Billion Profit, Shell Tops Estimates - October 31st, 2008
- Volkswagen’s Racing Shares Fueled by Porsche Investment - October 30th, 2008
- Tight Credit for Farmers Leads to Smaller Crops, Higher Prices and More Hunger - October 28th, 2008
- Business Week’s Gene Marcial’s New Stock Picks - October 28th, 2008
![]() About CEO Blogger (http://ceoblogger.wordpress.com)
CEOBlogger helps investors evaluate companies. |




